These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9071061)

  • 1. Molecular biology of head and neck tumorigenesis: the role of p53 expression and genetic instability.
    Charuruks N; Voravud N
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S3-10. PubMed ID: 9071061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic instability and the role of p53 mutations in cancer cells.
    Smith ML; Fornace AJ
    Curr Opin Oncol; 1995 Jan; 7(1):69-75. PubMed ID: 7696366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1996 Dec; 79 Suppl 1():S104-12. PubMed ID: 9071074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
    Crowe DL; Sinha UK
    Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
    Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumor suppressor gene p53: mechanisms of action in cell proliferation and death].
    Mendoza-Rodríguez CA; Cerbón MA
    Rev Invest Clin; 2001; 53(3):266-73. PubMed ID: 11496714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of aberrant p53 protein in head-neck tumors and its effect on proliferation and differentiation].
    Homann N; Andl T; Nees M; Schuhmann A; Herold-Mende C; Bosch FX
    HNO; 1993 May; 41(5):254-60. PubMed ID: 8392993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [p53--a gene for suppression of tumors?].
    Wustrow TD
    HNO; 1993 May; 41(5):A12-3. PubMed ID: 8335485
    [No Abstract]   [Full Text] [Related]  

  • 10. Indistinct cell cycle checkpoint after u.v. damage in H-ras-transformed mouse liver cells despite normal p53 gene expression.
    Kadohama T; Tsuji K; Ogawa K
    Oncogene; 1994 Oct; 9(10):2845-52. PubMed ID: 8084590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checking on the cell cycle.
    Mercer WE
    J Cell Biochem Suppl; 1998; 30-31():50-4. PubMed ID: 9893255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U; Danishefsky K; Traganos F; Darzynkiewicz Z
    Clin Cancer Res; 1995 Aug; 1(8):873-80. PubMed ID: 9816057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells.
    Wyllie FS; Haughton MF; Blaydes JP; Schlumberger M; Wynford-Thomas D
    Oncogene; 1995 Jan; 10(1):49-59. PubMed ID: 7529918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA; Xi S; Pomerantz RG; Lin CJ; Gooding WE; Wentzel AL; Wu L; Sidransky D; Grandis JR
    Head Neck; 2004 Oct; 26(10):870-7. PubMed ID: 15390206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK; Liu TJ; Frederick MJ; Clayman GL
    Clin Cancer Res; 1998 Sep; 4(9):2265-72. PubMed ID: 9748148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic mutation of the p53 gene derived from head and neck cancer prevents cells from undergoing apoptosis after DNA damage.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Shinagawa Y; Tachibana M; Imai Y; Fujimori T
    Int J Oncol; 2007 May; 30(5):1089-97. PubMed ID: 17390010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p53 network in lung carcinogenesis.
    Robles AI; Linke SP; Harris CC
    Oncogene; 2002 Oct; 21(45):6898-907. PubMed ID: 12362272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genomic instability in the pathogenesis of squamous cell carcinoma of the head and neck.
    Wiseman SM; Stoler DL; Anderson GR
    Surg Oncol Clin N Am; 2004 Jan; 13(1):1-11. PubMed ID: 15062358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of p53 and p16 gene alterations in determining response to concurrent paclitaxel and radiation in solid tumor.
    King TC; Estalilla OC; Safran H
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):4-11. PubMed ID: 10210535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.